Cyril Amarchand Mangaldas advises on bulk share sale in Syngene International by Biocon

Oct 10, 2022

Mumbai (Maharashtra)/ New Delhi [India], October 10 (ANI/BusinessWire India): Cyril Amarchand Mangaldas advised Biocon Limited (Biocon), in relation to the sale of shares by...

Biocon Biologics and Voluntis join hands for global collaboration on digital therapeutics for insulins

Jul 21, 2020

Bengaluru (Karnataka) [India], July 21 : Biocon Biologics India Limited, a fully integrated 'pure-play' biosimilars company, a subsidiary of Biocon Ltd. on Tuesday announced...

Biocon opens its first U.S. manufacturing facility in New Jersey

Sep 11, 2025

India's largest biopharmaceutical company, Biocon Limited, on Wednesday, announced the inauguration of its first U.S. manufacturing facility in Cranbury, New Jersey, by its wholly...

Biocon Biologics to offer 15 pc stake to Serum Institute Life Sciences at valuation of USD 4.9 billion

Sep 17, 2021

Bengaluru (Karnataka) [India], September 17 : Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS) announced...

Biocon Biologics to acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in stock and cash

Mar 01, 2022

Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), has entered into a...

Biocon Biologics completes acquisition of Viatris' Global Biosimilars Business

Nov 30, 2022

Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has...